fundamental and clinical studies were performed by our study group to evaluate the usefulness of the combination ( 1:1 ) of imipenem ( mk-0787 ) , a carbapenem antibiotic , and cilastatin sodium ( mk-0791 ) , an inhibitor of dehydropeptidase-i , in the treatment of patients with obstetric and gynecologic infections .
C0020933
imipenem
C0006968
carbapenem